To verify that TBX21 knockdown occurred specifically within tumor epithelial cells, we performed double immunofluorescence staining for TBX21 with EpCAM (tumor epithelial marker) and CD3 (T-cell marker). The gene discussed is EPCAM; the disease is neoplasm.